Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-26-043647

Chief Executive Officer sold 150,000 shares at an average $18.35 ($2,752,163)

From the SEC's structured data for this filing

Trades in this filing

Santos da Silva Jorge · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-10 Sale : show line 1 in the form −98,127 $18.41 $1,806,518 2,976,766 D
2026-04-13 Sale : show line 2 in the form −51,873 $18.23 $945,645 2,924,893 D
Open-market sales · 150,000 sh · avg $18.35 · $2,752,163
Loading xslF345X06/ownership.xml…